Thomas Gabrielczyk's articles Biotechnology UK Food Standards Agency accepts Gourmey’s application for cultivated Foie Gras The acceptance by the UK marks a new phase in what is emerging as a closely observed regulatory race. With similar food safety requirements across the EU, the US, Singapore, Switzerland and the UK, the process will provide insights into which regulatory frameworks are most efficient in assessing and approving novel food technologies. Earlier this […] Written by Thomas Gabrielczyk July 11, 2025July 11, 2025 Saving Bookmark this article Bookmarked Biotechnology EU Commissioner Várhelyi revives Biotech Act for 2025 In a panel discussion at Medicines for Europe Annual Conference, EU Health Commissioner Olivér Várhelyi made a surprise announcement that the Commission will adopt the EU Biotech Act by the end of this year, citing growing “global challenges”. According to the EU Commission’s work programme, the legislation was initially scheduled for adoption in Q3 2025, […] Written by Thomas Gabrielczyk June 28, 2025June 28, 2025 Saving Bookmark this article Bookmarked Biotechnology GEA to open food biotech pilot-scale facility in USA Similar to GEA’s initial scaling facility for cell-based food production in Germany, the recently opened 10,000-square-metre facility in Janesville, Wisconsin is intended to assist scientists and entrepreneurs in the developing food technology sector to increase their production to industrial levels. With a 40% market share and a thriving start-up scene, the US is ahead of […] Written by Thomas Gabrielczyk June 14, 2025June 14, 2025 Saving Bookmark this article Bookmarked Biotechnology EU set to improve investment for biotech start-ups and scale-ups The European Commission has unveiled a new strategy entitled ‘Choose Europe to start and scale’, which aims to strengthen the development and financing of start-ups and scale-ups within the European Union, particularly in innovation-driven sectors such as biotechnology, quantum computing and deep tech. The strategy, published on 28 May 2025, addresses the challenges faced by […] Written by Thomas Gabrielczyk June 1, 2025June 1, 2025 Saving Bookmark this article Bookmarked Biotechnology Countdown to SLAS Europe: NestEgg Labs BV Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […] Written by Thomas Gabrielczyk May 19, 2025May 19, 2025 Saving Bookmark this article Bookmarked Biotechnology Countdown to SLAS Europe: Minos Biosciences SAS Paris-based Minos Biosciences SAS’ (www.minos.bio) mission is to improve the understanding and treatment of complex diseases such as cancer, infectious and autoimmune diseases. As AI-powered drug discovery and therapeutic innovation holds great promise, the company’s MinoSuiteTM integrated cell analysis platform creates unprecedented multimodal datasets that will offer direct, ground-truth labels for AI training, opening up […] Written by Thomas Gabrielczyk May 5, 2025May 5, 2025 Saving Bookmark this article Bookmarked Biotechnology US President depriorises biotechnology – European Biotechnology Magazine The order was published and executed to advance engineering biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security. President Trump’s U-turn on biotechnology could soon turn out to be an own goal. The Republican senators from five federal states – Nebraska, Indiana, […] Written by Thomas Gabrielczyk March 20, 2025March 20, 2025 Saving Bookmark this article Bookmarked Biotechnology BRAIN Biotech partners with PX Group in microbial gold recycling Industrial biotech specialist BRAIN Biotech and PX Group have extended its collaboration in highly effective microbial gold recovery from e-waste. Back in 2017, BRAIN Biotech developed a container-based mobile pilot plant for the bioleaching of metals dubbed BioXtractor. An advanced version called BioXtractor V2 was financed by PX Group and is now jointly owned by […] Written by Thomas Gabrielczyk February 14, 2025February 14, 2025 Saving Bookmark this article Bookmarked Biotechnology SLAS: automation start ups set to enable P4 medicine Leroy Hood’s vision of P4 or ‘systemic’ medicine (preventive, predictive, personalised, participatory) is becoming a reality. By using omics data and medical records to create AI-powered individual health profiles, new automated product innovations aim to target diseases before symptoms even appear, reducing healthcare costs. On the second day of the SLAS 2025 conference, SLAS Ignite […] Written by Thomas Gabrielczyk January 29, 2025January 29, 2025 Saving Bookmark this article Bookmarked Biotechnology Merry Christmas and a Happy New Year European Biotechnology wishes its readers a Merry Christmas and a Happy New Year! We are taking a short winter break and will be back in January 2025 to provide you with the latest news, background reports, personalia and – in cooperation with our new partner, the Society for Laboratory Automation & Screening (SLAS) – updates […] Written by Thomas Gabrielczyk December 26, 2024December 26, 2024 Saving Bookmark this article Bookmarked Biotechnology Elevation Oncology Inc licences Synaffix BV’s ADC platform With the US$368m licence deal, Elevation Oncology, Inc is recognising Synaffix’s expertise in ADC development for the development of EO-1022. In contrast to Synaffix’s November deal with the Chinese BigHat Bioscience Co. Ltd, the US company does not book Lonza’s ADC manufacturing services that offers the same quality assurance process for all (clinicla) development phases, […] Written by Thomas Gabrielczyk December 13, 2024December 13, 2024 Saving Bookmark this article Bookmarked Biotechnology Tetraspecific B/NK cell better than T cell engagers The therapeutic landscape for relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) is evolving toward targeted T-cell based immunotherapies, including CD19-targeted CAR-T and CD3xCD20 T-cell engaging (TCE) bispecificantibodies. Yet, there remains an unmet medical need for patients who are refractory to, or ineligible for these treatments. Leveraging natural killer NK cells emerges as a promising […] Written by Thomas Gabrielczyk November 16, 2024November 16, 2024 Saving Bookmark this article Bookmarked Loading Load more
Biotechnology UK Food Standards Agency accepts Gourmey’s application for cultivated Foie Gras The acceptance by the UK marks a new phase in what is emerging as a closely observed regulatory race. With similar food safety requirements across the EU, the US, Singapore, Switzerland and the UK, the process will provide insights into which regulatory frameworks are most efficient in assessing and approving novel food technologies. Earlier this […] Written by Thomas Gabrielczyk July 11, 2025July 11, 2025 Saving Bookmark this article Bookmarked
Biotechnology EU Commissioner Várhelyi revives Biotech Act for 2025 In a panel discussion at Medicines for Europe Annual Conference, EU Health Commissioner Olivér Várhelyi made a surprise announcement that the Commission will adopt the EU Biotech Act by the end of this year, citing growing “global challenges”. According to the EU Commission’s work programme, the legislation was initially scheduled for adoption in Q3 2025, […] Written by Thomas Gabrielczyk June 28, 2025June 28, 2025 Saving Bookmark this article Bookmarked
Biotechnology GEA to open food biotech pilot-scale facility in USA Similar to GEA’s initial scaling facility for cell-based food production in Germany, the recently opened 10,000-square-metre facility in Janesville, Wisconsin is intended to assist scientists and entrepreneurs in the developing food technology sector to increase their production to industrial levels. With a 40% market share and a thriving start-up scene, the US is ahead of […] Written by Thomas Gabrielczyk June 14, 2025June 14, 2025 Saving Bookmark this article Bookmarked
Biotechnology EU set to improve investment for biotech start-ups and scale-ups The European Commission has unveiled a new strategy entitled ‘Choose Europe to start and scale’, which aims to strengthen the development and financing of start-ups and scale-ups within the European Union, particularly in innovation-driven sectors such as biotechnology, quantum computing and deep tech. The strategy, published on 28 May 2025, addresses the challenges faced by […] Written by Thomas Gabrielczyk June 1, 2025June 1, 2025 Saving Bookmark this article Bookmarked
Biotechnology Countdown to SLAS Europe: NestEgg Labs BV Founded in 2022 by Tanner Carden (CEO) and Hans Keijdener, Maastricht-based start-up NestEgg Labs BV focuses on developing interoperable automation systems for cell culture that reduce manual intervention, improve workflow reproducibility, and limit plastics waste. At the core of NestEgg’s offering is Ovation, a smart incubator platform designed to automate key stages of the cell […] Written by Thomas Gabrielczyk May 19, 2025May 19, 2025 Saving Bookmark this article Bookmarked
Biotechnology Countdown to SLAS Europe: Minos Biosciences SAS Paris-based Minos Biosciences SAS’ (www.minos.bio) mission is to improve the understanding and treatment of complex diseases such as cancer, infectious and autoimmune diseases. As AI-powered drug discovery and therapeutic innovation holds great promise, the company’s MinoSuiteTM integrated cell analysis platform creates unprecedented multimodal datasets that will offer direct, ground-truth labels for AI training, opening up […] Written by Thomas Gabrielczyk May 5, 2025May 5, 2025 Saving Bookmark this article Bookmarked
Biotechnology US President depriorises biotechnology – European Biotechnology Magazine The order was published and executed to advance engineering biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience, and national and economic security. President Trump’s U-turn on biotechnology could soon turn out to be an own goal. The Republican senators from five federal states – Nebraska, Indiana, […] Written by Thomas Gabrielczyk March 20, 2025March 20, 2025 Saving Bookmark this article Bookmarked
Biotechnology BRAIN Biotech partners with PX Group in microbial gold recycling Industrial biotech specialist BRAIN Biotech and PX Group have extended its collaboration in highly effective microbial gold recovery from e-waste. Back in 2017, BRAIN Biotech developed a container-based mobile pilot plant for the bioleaching of metals dubbed BioXtractor. An advanced version called BioXtractor V2 was financed by PX Group and is now jointly owned by […] Written by Thomas Gabrielczyk February 14, 2025February 14, 2025 Saving Bookmark this article Bookmarked
Biotechnology SLAS: automation start ups set to enable P4 medicine Leroy Hood’s vision of P4 or ‘systemic’ medicine (preventive, predictive, personalised, participatory) is becoming a reality. By using omics data and medical records to create AI-powered individual health profiles, new automated product innovations aim to target diseases before symptoms even appear, reducing healthcare costs. On the second day of the SLAS 2025 conference, SLAS Ignite […] Written by Thomas Gabrielczyk January 29, 2025January 29, 2025 Saving Bookmark this article Bookmarked
Biotechnology Merry Christmas and a Happy New Year European Biotechnology wishes its readers a Merry Christmas and a Happy New Year! We are taking a short winter break and will be back in January 2025 to provide you with the latest news, background reports, personalia and – in cooperation with our new partner, the Society for Laboratory Automation & Screening (SLAS) – updates […] Written by Thomas Gabrielczyk December 26, 2024December 26, 2024 Saving Bookmark this article Bookmarked
Biotechnology Elevation Oncology Inc licences Synaffix BV’s ADC platform With the US$368m licence deal, Elevation Oncology, Inc is recognising Synaffix’s expertise in ADC development for the development of EO-1022. In contrast to Synaffix’s November deal with the Chinese BigHat Bioscience Co. Ltd, the US company does not book Lonza’s ADC manufacturing services that offers the same quality assurance process for all (clinicla) development phases, […] Written by Thomas Gabrielczyk December 13, 2024December 13, 2024 Saving Bookmark this article Bookmarked
Biotechnology Tetraspecific B/NK cell better than T cell engagers The therapeutic landscape for relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) is evolving toward targeted T-cell based immunotherapies, including CD19-targeted CAR-T and CD3xCD20 T-cell engaging (TCE) bispecificantibodies. Yet, there remains an unmet medical need for patients who are refractory to, or ineligible for these treatments. Leveraging natural killer NK cells emerges as a promising […] Written by Thomas Gabrielczyk November 16, 2024November 16, 2024 Saving Bookmark this article Bookmarked
